Dark Forest Capital Management LP Kymera Therapeutics, Inc. Transaction History
Dark Forest Capital Management LP
- $718 Million
- Q3 2024
A detailed history of Dark Forest Capital Management LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Dark Forest Capital Management LP holds 4,410 shares of KYMR stock, worth $195,627. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,410Holding current value
$195,627% of portfolio
0.03%Shares
10 transactions
Others Institutions Holding KYMR
# of Institutions
183Shares Held
64.3MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$295 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$266 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$229 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$217 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$211 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.43B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...